Matches in Wikidata for { <http://www.wikidata.org/entity/Q66064422> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66064422 description "clinical trial" @default.
- Q66064422 description "ensayu clínicu" @default.
- Q66064422 description "klinisch onderzoek" @default.
- Q66064422 description "клінічне випробування" @default.
- Q66064422 name "Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure (ADHF) Who Have Been Stabilized During Hospitalization (PARAGLIDE-HF)" @default.
- Q66064422 name "Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure" @default.
- Q66064422 type Item @default.
- Q66064422 label "Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure (ADHF) Who Have Been Stabilized During Hospitalization (PARAGLIDE-HF)" @default.
- Q66064422 label "Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure" @default.
- Q66064422 prefLabel "Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure (ADHF) Who Have Been Stabilized During Hospitalization (PARAGLIDE-HF)" @default.
- Q66064422 prefLabel "Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure" @default.
- Q66064422 P1050 Q66064422-7F3AFA88-82A2-4A53-9786-DBD62E9DF45B @default.
- Q66064422 P1132 Q66064422-C4061F3F-53B2-42EB-8FD5-19463889F746 @default.
- Q66064422 P1476 Q66064422-630AC76F-5572-494E-9B02-982B9E50279B @default.
- Q66064422 P2899 Q66064422-09A465D5-BD44-4FF7-B980-CEBD30A18483 @default.
- Q66064422 P3098 Q66064422-AE45492C-131E-4F47-8142-89DA6DD662C4 @default.
- Q66064422 P31 Q66064422-4829779E-21A7-4610-B5C4-F7A966E2B80E @default.
- Q66064422 P4844 Q66064422-B01798D1-9EC3-4E7A-BAC8-D8EC6D7442C1 @default.
- Q66064422 P580 Q66064422-DC2F6E66-0BB9-4D26-85BB-A6CDC8C1DA31 @default.
- Q66064422 P582 Q66064422-A1A6893B-2B5A-45F6-894C-B3D72F120C4F @default.
- Q66064422 P6099 Q66064422-166C105E-B556-4E66-A031-B4595ACCF471 @default.
- Q66064422 P6153 Q66064422-FC54103C-0B43-4DF3-A350-36F151F12671 @default.
- Q66064422 P8363 Q66064422-4CF11014-77B3-4BBE-9F81-F8DDB85B3CDD @default.
- Q66064422 P859 Q66064422-3F64EC75-432F-4183-8E8C-EA7770F696D7 @default.
- Q66064422 P1050 Q181754 @default.
- Q66064422 P1132 "+616" @default.
- Q66064422 P1476 "A Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group, Active Controlled 8-week Study to Evaluate the Effect of Sacubitril/Valsartan (LCZ696) Versus Valsartan on Changes in NT-proBNP and Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure (ADHF) Who Have Been Stabilized During Hospitalization (PARAGLIDE-HF)" @default.
- Q66064422 P2899 "+40" @default.
- Q66064422 P3098 "NCT03988634" @default.
- Q66064422 P31 Q30612 @default.
- Q66064422 P4844 Q7912612 @default.
- Q66064422 P580 "2019-06-19T00:00:00Z" @default.
- Q66064422 P582 "2021-02-11T00:00:00Z" @default.
- Q66064422 P6099 Q42824827 @default.
- Q66064422 P6153 Q507154 @default.
- Q66064422 P8363 Q78089383 @default.
- Q66064422 P859 Q507154 @default.